Holen Sie sich die Stockscreener-App
10.04
1.93%
0.19
Handel nachbörslich:
10.04
Pavmed Inc Aktie (PAVM) Neueste Nachrichten
Can PAVmed Inc expand into new marketsTrade Exit Report & Growth Oriented Trading Recommendations - baoquankhu1.vn
Q3 2025 PAVmed Inc Earnings Call Transcript - GuruFocus
Big Money Moves: Whats next for PAVmed Inc stockBuy Signal & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
PAVM Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
PAVmed (PAVM) CEO Lishan Aklog awarded 350,000 restricted shares vesting 2029 - Stock Titan
Craig Kallman (PAVM) holds 384,616 shares, a 6.0% stake in PAVmed - Stock Titan
PAVmed (PAVM) CFO awarded 180,000 restricted shares vesting 2029 - Stock Titan
Director at PAVmed (PAVM) receives 13,930 restricted stock shares - Stock Titan
PAVmed (PAVM) director Timothy Baxter receives 13,930 restricted shares vesting in 2029 - Stock Titan
Restricted stock grant boosts PAVmed (PAVM) director’s holdings - Stock Titan
PAVmed (PAVM) director gets 13,930-share restricted stock grant - Stock Titan
Restricted stock award boosts PAVmed (NASDAQ: PAVM) director stake - Stock Titan
Tasso Partners and Dana Carrera disclose 14.3% stake in PAVmed (PAVM) - Stock Titan
PAVmed (PAVM) general counsel receives 110,000-share restricted award - Stock Titan
PAVmed (PAVM) COO receives 110,000-share restricted stock grant vesting 2029 - Stock Titan
Lucid Diagnostics Inc. (LUCD) stock price, news, quote and history - Yahoo Finance UK
PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio - Bitget
PAVmed appoints Joseph Virgilio as medical device chief By Investing.com - Investing.com Australia
PAVmed raises $45 million, restructures capital to eliminate convertible debt - Investing.com
PAVmed: Octeris, Inc. Subsidiary Formed to Advance Endoscopic Esophageal Imaging Tech Recently Licensed From Duke University >PAVM - Moomoo
PAVmed appoints Joseph Virgilio as medical device chief - Investing.com
PAVM Technical Analysis | Trend, Signals & Chart Patterns | PAVMED INC (NASDAQ:PAVM) - ChartMill
PAVmed Inc. (NASDAQ:PAVM) Q4 2025 Earnings Call Transcript - Insider Monkey
PAVmed raises $45 million, restructures capital to eliminate convertible debt By Investing.com - Investing.com India
Maxim Group Maintains PAVmed(PAVM.US) With Buy Rating, Cuts Target Price to $16 - Moomoo
PAVmed Inc. Q4 2025 Earnings Call Summary - finance.yahoo.com
Fundamentals Check: Is PAVmed Inc a potential multi baggerWeekly Profit Recap & High Conviction Buy Zone Picks - baoquankhu1.vn
PAVmed completes $45M financing, eliminates convertible debt By Investing.com - Investing.com Australia
PAVmed (PAVM) upgraded to buy: Here's what you should know - MSN
PAVmed Inc (PAVM) Q4 2025 Earnings Call Highlights: Strategic Re - GuruFocus
PAVmed Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:PAVM) 2026-03-30 - Seeking Alpha
PAVmed (PAVM) Upgraded to Buy: Here's What You Should Know - finance.yahoo.com
PAVM: Q4 2025 featured diagnostic revenue growth, a VA contract, and improved non-GAAP loss per share - TradingView
PAVmed Reports 2025 Financial Results, Strengthens Capital Structure, and Expands Medical Device Portfolio Under New Leadership - Minichart
Earnings call transcript: PAVmed Q4 2025 shows restructuring gains By Investing.com - Investing.com India
Earnings call transcript: PAVmed Q4 2025 shows restructuring gains - Investing.com
PAVM: Restructuring and growth initiatives drive commercial momentum and financial stability - TradingView
PAVmed Reports Q4 2025 Financial Results with Key Metrics - Intellectia AI
PAVmed Reports 2025 Results, Strengthens Balance Sheet - TipRanks
Q4 2025 PAVmed Inc Earnings Call Transcript - GuruFocus
PAVmed completes $45M financing, eliminates convertible debt - investing.com
PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results - Bitget
PAVmed (NASDAQ: PAVM) overhauls capital structure and reports 2025 results - Stock Titan
PAVM: Q4 2025 featured capital restructuring, expanded diagnostics, and improved financials - TradingView
PAVmed Q4 2025 Earnings Call Transcript - MarketBeat
PAVmed to Announce Q4 Earnings on March 30 - Intellectia AI
PAVmed Q2 2025 Earnings Preview - MSN
PAVmed Inc. 8-K Filing Details: Company Information, Nasdaq Listing, and 2026 Shareholder Meeting Results - Minichart
PAVmed Inc. 2025 Annual Report: Financials, Risk Factors, and Corporate Governance Overview - Minichart
Bear Alert: Whats next for PAVmed Inc stock2026 Sector Moves & Safe Capital Growth Tips - baoquankhu1.vn
PAVmed's Capital Cleanup Hides High-Reward Catalyst for Patient Biotech Investors - Bitget
PAVmed Shareholders Approve Equity Issuance and Governance Changes - TipRanks
PAVmed shareholders approve stock issuance, charter amendment, and equity plan changes - Investing.com UK
PAVmed (NASDAQ: PAVM) holders approve stock issuances and expand equity plan - stocktitan.net
PAVmed 2025 10-K: Revenue $0.1M; loss before noncontrolling interests ~$2.5M - TradingView
PAVmed (PAVM) outlines going concern risk, Nasdaq compliance and growth plans - stocktitan.net
PAVmed Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
PAVmed Inc Extraordinary Shareholders Meeting Transcript - GuruFocus
What To Expect From PAVmed Inc (PAVM) Q4 2025 Earnings - GuruFocus
Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results - StreetInsider
[EFFECT] Lucid Diagnostics Inc. SEC Filing - Stock Titan
Lucid Diagnostics reports Q4 revenue of $1.5M, VA contract By Investing.com - Investing.com South Africa
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):